# Kazia Therapeutics Ltd: financial statements, quarterly

KZIA · Nasdaq · CIK 1075880 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/kzia.md) · [Financials](/companies/kzia/financials.md) · [Filings](/companies/kzia/filings.md) · [Insiders](/companies/kzia/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/kzia/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2015-06-30) | period not labelled (2016-06-30) | period not labelled (2017-06-30) | FY2018 (2018-06-30) | FY2019 (2019-06-30) | FY2020 (2020-06-30) | FY2021 (2021-06-30) | FY2022 (2022-06-30) | FY2023 (2023-06-30) | FY2024 (2024-06-30) | FY2025 (2025-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [44.4](/filings/0001193125-18-305893.md) | [33.5](/filings/0001193125-19-270437.md) | [14.5](/filings/0001193125-20-274018.md) | [6.0](/filings/0001193125-21-293688.md) | [5.4](/filings/0001193125-22-263335.md) | [8.8](/filings/0001193125-23-263551.md) | [27.6](/filings/0001193125-24-259805.md) | [7.4](/filings/0001193125-25-272284.md) | [5.2](/filings/0001193125-25-272284.md) | [1.7](/filings/0001193125-25-272284.md) | [4.3](/filings/0001193125-25-272284.md) |
| Current assets | $m | not reported | not reported | [19.5](/filings/0001193125-18-305893.md) | [9.3](/filings/0001193125-19-270437.md) | [7.5](/filings/0001193125-20-274018.md) | [10.7](/filings/0001193125-21-293688.md) | [29.4](/filings/0001193125-22-263335.md) | [9.4](/filings/0001193125-23-263551.md) | [10.8](/filings/0001193125-24-259805.md) | [6.1](/filings/0001193125-25-272284.md) | [4.9](/filings/0001193125-25-272284.md) |
| Total assets | $m | not reported | not reported | [35.9](/filings/0001193125-18-305893.md) | [28.2](/filings/0001193125-19-270437.md) | [21.2](/filings/0001193125-20-274018.md) | [23.1](/filings/0001193125-21-293688.md) | [58.1](/filings/0001193125-22-263335.md) | [35.9](/filings/0001193125-23-263551.md) | [28.1](/filings/0001193125-24-259805.md) | [21.6](/filings/0001193125-25-272284.md) | [6.1](/filings/0001193125-25-272284.md) |
| Current liabilities | $m | not reported | not reported | [5.4](/filings/0001193125-18-305893.md) | [3.9](/filings/0001193125-19-270437.md) | [1.9](/filings/0001193125-20-274018.md) | [5.1](/filings/0001193125-21-293688.md) | [8.3](/filings/0001193125-22-263335.md) | [6.7](/filings/0001193125-23-263551.md) | [7.6](/filings/0001193125-24-259805.md) | [25.8](/filings/0001193125-25-272284.md) | [14.1](/filings/0001193125-25-272284.md) |
| Total liabilities | $m | not reported | not reported | [10.6](/filings/0001193125-18-305893.md) | [8.9](/filings/0001193125-19-270437.md) | [7.0](/filings/0001193125-20-274018.md) | [8.9](/filings/0001193125-21-293688.md) | [20.2](/filings/0001193125-22-263335.md) | [17.6](/filings/0001193125-23-263551.md) | [16.0](/filings/0001193125-24-259805.md) | [31.6](/filings/0001193125-25-272284.md) | [14.4](/filings/0001193125-25-272284.md) |
| Shareholders' equity | $m | [44.4](/filings/0001193125-18-305893.md) | [33.9](/filings/0001193125-19-270437.md) | [25.3](/filings/0001193125-18-305893.md) | [19.2](/filings/0001193125-19-270437.md) | [14.2](/filings/0001193125-20-274018.md) | [14.1](/filings/0001193125-21-293688.md) | [37.9](/filings/0001193125-22-263335.md) | [18.3](/filings/0001193125-23-263551.md) | [12.1](/filings/0001193125-24-259805.md) | [(10.0)](/filings/0001193125-25-272284.md) | [(8.3)](/filings/0001193125-25-272284.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 809,418,734 at 2025-06-30, from the cover of the [20-F filed 2025-11-07](/filings/0001193125-25-272284.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.